Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

June 30, 2004

Conditions
Graft-versus-Host Disease
Interventions
DRUG

Methoxsalen

PROCEDURE

Extracorporeal Photopheresis

Trial Locations (21)

2010

St. Vincent's Hospital, Sydney

3050

Royal Melbourne Hospital, Parkville

4006

Royal Brisbane Hospital, Brisbane

6100

Ankara University Medical School, Ankara

8006

Peter MacCallum Cancer Institute, East Melbourne

16132

San Martino Hospital, Genova

32611

University of Florida, Gainesville

44195

Cleveland Clinic Foundation, Cleveland

60637

University of Chicago, Chicago

64111

Kansas City Cancer Center, Kansas City

78229

Texas Transplant, San Antonio

02111

Tufts New England Medical Center, Boston

Unknown

Alfred Hospital, Melbourne

Hospital Azevedo Carvalho, Jaú

National Cancer Institute, Rio de Janeiro

Hemocentro, São Paulo

National Cancer Institute, Bratislava

D-81377

Ludwig-Maximiliano Universitaet Muenchen, München

1-50134

Careggi Hospital, Florence

1099-023

Instituto Portugues de Oncologia de Francisco Gentil, Lisbon

W12 0NN

Hammersmith Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mallinckrodt

INDUSTRY